UNSPSC 51294702: Nomelidine

This classification denotes an antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FVL27C1DMG. European Medicines Agency schedules Nomelidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09346MIG. Nomelidine generally arises in the molecular formula C15H15BRN2.

UNSPSC 51294702 Nomelidine is a Commodity code that in recent state and local procurement covers naloxone and drug deactivation systems purchased to support community health and emergency response initiatives. State and local health departments and county community health agencies solicit under this code to equip public health programs with life-saving opioid antagonists and controlled-substance disposal equipment. Purchases include both the pharmaceutical product (naloxone) and complementary systems for safe deactivation of seized or surplus drugs. Issuing bodies are typically county health departments and municipal public health offices rather than broader state agencies or school districts.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract term runs two years with a one-year renewal option, and vendors must include all shipping and delivery costs in their proposal, comply with E-Verify and drug-free workplace certification, and carry workers' compensation, commercial general liability, and professional liability insurance. The procurement is potentially funded through FEMA and therefore subject to federal environmental compliance requirements. No explicit set-aside designations are specified. Recent activity under this code appears limited to the Seminole County opportunity; broader geographic or issuing-body patterns are not evident from available posted solicitations.